Carr Kathleen, Henchal Erik A, Wilhelmsen Catherine, Carr Bridget
U S Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702, USA.
Biosecur Bioterror. 2004;2(1):7-16. doi: 10.1089/153871304322964291.
New biosurety regulations and guidelines were implemented in 2003 because of increased concern for the safety and security of biological select agents and toxins (BSAT) that may be used as weapons of mass destruction. Biosurety is defined as the combination of security, biosafety, agent accountability, and personnel reliability needed to prevent unauthorized access to select agents of bioterrorism. These new regulations will lead to increased scrutiny of the use of select biological agents in registered research laboratories, but the regulations may have unintended effects on cost, progress, and perceptions in programs previously considered part of the academic research community. We review the history of biosurety, evolving guidelines, implementation of the regulations, and impacts at the lead research laboratory for medical biological defense for the Department of Defense.
由于对可能被用作大规模杀伤性武器的生物选择剂和毒素(BSAT)的安全和安保问题日益担忧,2003年实施了新的生物安保法规和准则。生物安保被定义为防止未经授权获取生物恐怖主义选择剂所需的安全、生物安全、制剂问责制和人员可靠性的组合。这些新法规将导致对注册研究实验室中选择生物制剂使用的审查增加,但这些法规可能会对以前被视为学术研究界一部分的项目的成本、进展和认知产生意想不到的影响。我们回顾了生物安保的历史、不断演变的准则、法规的实施以及对国防部医学生物防御牵头研究实验室的影响。